We searched various online data sources, including Scopus, Medline (PubMed), Web of Science, The Cochrane Library,
Embase (Elsevier), and Google Scholar from January 1, 2019, to February 28, 2021, and updated on March 25, 2021. All types of studies, including original research studies, clinical perspective, case series/reports, editorials, and commentaries were assessed. Studies on COVID-19 vaccinated individuals (with any type of COVID-19 vaccine with the United States FDA approval) presented with LAP by various imaging modalities such as sonography, mammography, MRI, PET/CT scan, and PET/MRI were included. Duplicates, studies reported other adverse events of COVID-19 vaccines rather than adenopathy, and studies without available full text were excluded. Keywords of literature search included “COVID-19,” “coronavirus disease,” “SARS-CoV-19,” “Vaccin*,” and “Vaccination,” “Immunization,” “side effect*,” “adenopath*,” and “Lymphadenopathy.” The details of the PubMed keywords search strategy are presented in appendix A.
Keshavarz P., Yazdanpanah F., Rafiee F, & Mizandari M. (2021). Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review. Academic Radiology, 28(8), 1058-1071.